Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Isolation of viable antigen-specific CD8+ T cells based on membrane-bound tumor necrosis factor (TNF)-α expression.

Haney D, Quigley MF, Asher TE, Ambrozak DR, Gostick E, Price DA, Douek DC, Betts MR.

J Immunol Methods. 2011 Jun 30;369(1-2):33-41. doi: 10.1016/j.jim.2011.04.003. Epub 2011 Apr 8.

2.

Type I interferon supports primary CD8+ T-cell responses to peptide-pulsed dendritic cells in the absence of CD4+ T-cell help.

Ontiveros F, Wilson EB, Livingstone AM.

Immunology. 2011 Apr;132(4):549-58. doi: 10.1111/j.1365-2567.2010.03400.x. Epub 2011 Jan 24.

4.

Detection and quantification of blood-derived CD8+ T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens.

Herr W, Schneider J, Lohse AW, Meyer zum Büschenfelde KH, Wölfel T.

J Immunol Methods. 1996 May 27;191(2):131-42.

PMID:
8666832
5.

Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.

Bedini C, Nasorri F, Girolomoni G, Pità Od, Cavani A.

Br J Dermatol. 2007 Aug;157(2):249-58. Epub 2007 May 8.

PMID:
17489975
6.

Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.

Zou J, Rudwaleit M, Brandt J, Thiel A, Braun J, Sieper J.

Arthritis Rheum. 2003 Mar;48(3):780-90.

7.
8.

T lymphocyte-derived TNF and IFN-γ repress HFE expression in cancer cells.

Reuben A, Godin-Ethier J, Santos MM, Lapointe R.

Mol Immunol. 2015 Jun;65(2):259-66. doi: 10.1016/j.molimm.2015.01.029. Epub 2015 Feb 18.

PMID:
25700349
9.

Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity.

Mirandola P, Ponti C, Gobbi G, Sponzilli I, Vaccarezza M, Cocco L, Zauli G, Secchiero P, Manzoli FA, Vitale M.

Blood. 2004 Oct 15;104(8):2418-24. Epub 2004 Jun 17.

10.

Regulation of gammadelta T cell survival by soluble HLA-I: involvement of CD8 and activating killer Ig-like receptors.

Poggi A, Contini P, Catellani S, Setti M, Murdaca G, Zocchi MR.

Eur J Immunol. 2005 Sep;35(9):2670-8.

11.

HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function.

Appay V, Nixon DF, Donahoe SM, Gillespie GM, Dong T, King A, Ogg GS, Spiegel HM, Conlon C, Spina CA, Havlir DV, Richman DD, Waters A, Easterbrook P, McMichael AJ, Rowland-Jones SL.

J Exp Med. 2000 Jul 3;192(1):63-75.

12.

A new method for detecting TNF-alpha-secreting cells using direct-immunofluorescence surface membrane stainings.

Bueno C, Rodriguez-Caballero A, García-Montero A, Pandiella A, Almeida J, Orfao A.

J Immunol Methods. 2002 Jun 1;264(1-2):77-87.

PMID:
12191512
14.
15.

The expansion ability but not the quality of HIV-specific CD8(+) T cells is associated with protective human leucocyte antigen class I alleles in long-term non-progressors.

López M, Peris A, Soriano V, Lozano S, Vicario JL, Rallón NI, Restrepo C, Benito JM.

Immunology. 2011 Nov;134(3):305-13. doi: 10.1111/j.1365-2567.2011.03490.x.

16.

Aplastic anemia rescued by exhaustion of cytokine-secreting CD8+ T cells in persistent infection with lymphocytic choriomeningitis virus.

Binder D, van den Broek MF, Kägi D, Bluethmann H, Fehr J, Hengartner H, Zinkernagel RM.

J Exp Med. 1998 Jun 1;187(11):1903-20.

17.

Anti-leukemia T cells in AML: TNF-α⁺ CD8⁺ T cells may escape detection and possibly reflect a stage of functional impairment.

Flörcken A, van Lessen A, Terwey TH, Dörken B, Arnold R, Pezzutto A, Westermann J.

Hum Vaccin Immunother. 2013 Jun;9(6):1200-4. doi: 10.4161/hv.24250. Epub 2013 Apr 8.

18.
19.

Critical role for CD1d-restricted invariant NKT cells in stimulating intrahepatic CD8 T-cell responses to liver antigen.

Sprengers D, Sillé FC, Derkow K, Besra GS, Janssen HL, Schott E, Boes M.

Gastroenterology. 2008 Jun;134(7):2132-43. doi: 10.1053/j.gastro.2008.02.037. Epub 2008 Feb 21.

PMID:
18549881
20.

Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.

Brando C, Mukhopadhyay S, Kovacs E, Medina R, Patel P, Catina TL, Campbell KS, Santoli D.

J Leukoc Biol. 2005 Aug;78(2):359-71. Epub 2005 Jun 3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk